Hospital Henri-Mondor
Créteil 94010
4 studies enrolling now · 9 studies all time
What they study most
Carcinoma, Hepatocellular, Chronic Shift Work Sleep Disorder, Essential Thrombocythemia, Excessive Daytime Sleepiness, HIV Infections, Hepatitis C, Huntington's Disease, Immune Thrombocytopenic Purpura (ITP), Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, Primary Biliary Cholangitis (PBC), Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Studies at this site
- A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia — Recruiting now
- A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia — Recruiting now
- A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis — Recruiting now
- CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis — Recruiting now
- Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease — Stopped early
- Efficacy and Safety Doxorubicin Transdrug Study in Patients Suffering From Advanced Hepatocellular Carcinoma — Completed
- A Rollover Study for Subjects Participating in the Control Arm of Study VX06-950-106, VX05-950-104 and VX05-950-104EU Whose Plasma Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) Levels Did Not Respond to Therapy — Completed
- Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness — Completed
- Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx — Completed